An interventional study of Symbicort and Formoterol in Exercise Performance, sponsored by Morten Hostrup, PhD. Completed at 1 site in Denmark. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-13.
Sponsored by Morten Hostrup, PhD · Not applicable, Interventional, and Basic science
The purpose of the project is to investigate exercise performance in well-trained individuals in a crossover design following varying degrees of bronchodilation/constriction intervention using current standard procedures.
Morten Hostrup, PhD is the lead sponsor of 14 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants are administered Formoterol + Budesonide from an inhaler device testing. In addition, participants are administered a placebo capsule, which is taken orally.
Drug: Symbicort
Participants are administered Formoterol from an inhaler device testing. In addition, participants are administered a placebo capsule, which is taken orally.
Drug: Formoterol
Participants are administered a Formoterol capsule, which is taken orally. In addition, participants are administered placebo from an inhaler device.
Drug: Formoterol
Participants are administered placebo from an inhaler device testing and a placebo capsule.
Drug: Placebo
Participants are administered Bronchitol from an inhaler device testing.
Drug: Mannitol
Participants are administered 54 μg Formoterol and 1920 μg Budesonide
Participants are administered 54 μg Formoterol from an inhaler device
Participants are administered 120 μg Formoterol in a capsule, which is taken orally
Participants are administered placebo
Participants are administered 600 mg Bronchitol
Power output during time trial
Mean power output measured in Watts during a time trial on a bike ergometer
Time frame: Through study completion, an average on 4 weeks
Power output during sprint testing
Power output measured in Watts during a sprint on a bike ergometer
Time frame: Through study completion, an average on 4 weeks
Quadriceps strength
Maksimal torque (Nm) achieved during isometric contraction
Time frame: Through study completion, an average on 4 weeks
Forced Expiratory Volume in 1 second (FEV1)
FEV1 measured by spirometry
Time frame: Through study completion, an average on 4 weeks
Respiratory muscle function
Mouth inspiratory and expiratory pressures against a closed system
Time frame: Through study completion, an average on 4 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Morten Hostrup, PhD